v3.26.1
Condensed Statements of Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock (Class A and B)
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at the beginning (in shares) at Dec. 31, 2024   34,174,668      
Balance at the beginning at Dec. 31, 2024 $ 47,803 $ 3 $ 327,534 $ 60 $ (279,794)
Issuance of common stock upon exercise of stock options (in shares)   45,949      
Issuance of common stock upon exercise of stock options 47   47    
Issuance of restricted stock units (in shares)   318,154      
Issuance of common stock and pre-funded warrants (in shares)   3,125,000      
Issuance of common stock and pre-funded warrants 53,611 $ 1 53,610    
Stock-based compensation expense 1,493   1,493    
Other comprehensive income (loss) 16     16  
Net loss (8,187)       (8,187)
Balance at the ending (in shares) at Mar. 31, 2025   37,663,771      
Balance at the ending at Mar. 31, 2025 94,783 $ 4 382,684 76 (287,981)
Balance at the beginning (in shares) at Dec. 31, 2024   34,174,668      
Balance at the beginning at Dec. 31, 2024 47,803 $ 3 327,534 60 (279,794)
Other comprehensive income (loss) 85        
Net loss (16,233)        
Balance at the ending (in shares) at Jun. 30, 2025   38,026,154      
Balance at the ending at Jun. 30, 2025 88,226 $ 4 384,104 145 (296,027)
Balance at the beginning (in shares) at Mar. 31, 2025   37,663,771      
Balance at the beginning at Mar. 31, 2025 94,783 $ 4 382,684 76 (287,981)
Issuance of common stock upon exercise of stock options (in shares)   519      
Issuance of common stock upon exercise of stock options 1   1    
Issuance of restricted stock units (in shares)   305,220      
Issuance of common stock under employee stock purchase plan (in shares)   56,644      
Issuance of common stock under employee stock purchase plan 75   75    
Stock-based compensation expense 1,344   1,344    
Other comprehensive income (loss) 69     69  
Net loss (8,046)       (8,046)
Balance at the ending (in shares) at Jun. 30, 2025   38,026,154      
Balance at the ending at Jun. 30, 2025 88,226 $ 4 384,104 145 (296,027)
Balance at the beginning (in shares) at Dec. 31, 2025   38,944,523      
Balance at the beginning at Dec. 31, 2025 75,408 $ 4 386,864 262 (311,722)
Issuance of common stock upon exercise of stock options (in shares)   12,016      
Issuance of common stock upon exercise of stock options 22   22    
Issuance of restricted stock units (in shares)   187,309      
Stock-based compensation expense 835   835    
Other comprehensive income (loss) (246)     (246)  
Net loss (8,399)       (8,399)
Balance at the ending (in shares) at Mar. 31, 2026   39,143,848      
Balance at the ending at Mar. 31, 2026 67,620 $ 4 387,721 16 (320,121)
Balance at the beginning (in shares) at Dec. 31, 2025   38,944,523      
Balance at the beginning at Dec. 31, 2025 $ 75,408 $ 4 386,864 262 (311,722)
Issuance of common stock upon exercise of stock options (in shares) 36,587        
Other comprehensive income (loss) $ (310)        
Net loss (17,538)        
Balance at the ending (in shares) at Jun. 30, 2026   39,437,969      
Balance at the ending at Jun. 30, 2026 59,380 $ 4 388,684 (48) (329,260)
Balance at the beginning (in shares) at Mar. 31, 2026   39,143,848      
Balance at the beginning at Mar. 31, 2026 67,620 $ 4 387,721 16 (320,121)
Issuance of common stock upon exercise of stock options (in shares)   24,571      
Issuance of common stock upon exercise of stock options 41   41    
Issuance of restricted stock units (in shares)   215,742      
Issuance of common stock under employee stock purchase plan (in shares)   53,808      
Issuance of common stock under employee stock purchase plan 99   99    
Stock-based compensation expense 823   823    
Other comprehensive income (loss) (64)     (64)  
Net loss (9,139)       (9,139)
Balance at the ending (in shares) at Jun. 30, 2026   39,437,969      
Balance at the ending at Jun. 30, 2026 $ 59,380 $ 4 $ 388,684 $ (48) $ (329,260)